Filing status
- Accounts due
- 31 December 2026
- Last accounts
- 31 March 2025
- Conf. stmt due
- 22 November 2026
- Last conf. stmt
- 8 November 2025
Birmingham Centre for Cancer and Genomic Medicine LLP
- Incorporated
- 9 November 2022 (4 years)
- Industry
- None Supplied (None Supplied)
- Controlled by
- Accounts type
- Unaudited abridged
- Region
- West Midlands
- Address
- C/o Medmin Services Ltd3rd FloorTrigate HouseHagley Road WestBirminghamB68 0NP
Officers
Not loaded yet. See them on Companies House
Ownership 2 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 1 December 2022
Right to appoint and remove members
Limited Company
Reg. no. 13287734
Limited Company
Reg. no. 13266500
Financials
Figures from 2024 accounts. Newer accounts, made up to 31 March 2025, are filed but not read yet. See them on Companies House
- Cash
- £600
- Turnover
- £7,850
- Profit
- £0
- Current Ratio
- 1.0x
Trend
Turnover
Balance sheet detail
| 2024 | 2023 | |
|---|---|---|
| Current Assets | £5,650 | |
| Debtors | £5,050 | |
| Cash | £600 | £3 |
| Creditors (< 1 year) | £5,645 | |
| Net Current Assets | £5 | |
| Turnover | £7,850 | £0 |
| Cost of Sales | £6,282 | |
| Gross Profit | £1,568 | |
| Admin Expenses | £1,568 | |
| Profit for Period | £0 | £0 |
Filings
Filing history not loaded yet. See it on Companies House
Some other companies at this address
Other companies in this industry
London
Bury St. Edmunds
Spalding
London
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →